Naltrexone HCl: Clinically Proven Alcohol Craving Reduction
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.18 | $215.28 (0%) | 🛒 Add to cart |
| 60 | $6.79 | $430.56 $407.42 (5%) | 🛒 Add to cart |
| 90 | $6.65
Best per pill | $645.84 $598.56 (7%) | 🛒 Add to cart |
Synonyms | |||
Naltrexone hydrochloride is a prescription medication approved by the FDA for the management of alcohol dependence in combination with comprehensive behavioral therapy. As an opioid antagonist, it works by binding to opioid receptors in the brain, effectively reducing the euphoric effects and cravings associated with alcohol consumption. This pharmacological action supports patients in maintaining abstinence and reduces the risk of relapse, making it a cornerstone in modern addiction treatment protocols. Proper usage under medical supervision can significantly improve long-term recovery outcomes.
Features
- Active ingredient: Naltrexone Hydrochloride 50 mg
- Formulation: Oral tablet
- Mechanism: Opioid receptor antagonist
- Prescription requirement: Yes
- Manufacturer compliance: cGMP certified
- Packaging: Blister packs, 30 tablets
Benefits
- Reduces alcohol craving intensity by modulating brain reward pathways
- Decreases the perceived pleasurable effects of alcohol if consumed
- Supports long-term abstinence when combined with counseling
- Lowers relapse rates in patients with alcohol use disorder
- Improves treatment adherence through once-daily dosing
- Non-addictive profile with no abuse potential
Common use
Naltrexone HCl is indicated for use in adults as part of a comprehensive treatment program for alcohol dependence. It is typically prescribed after patients have achieved initial abstinence through detoxification. The medication is used to help maintain sobriety by reducing the desire to drink and diminishing the reinforcing effects of alcohol. It is most effective when combined with psychosocial support, such as cognitive behavioral therapy, motivational enhancement, or participation in support groups. Treatment is generally initiated after a thorough medical evaluation confirms the absence of acute withdrawal symptoms or recent opioid use.
Dosage and direction
The standard dosage for alcohol dependence is 50 mg once daily, with or without food. Treatment should be initiated under medical supervision after the patient has remained opioid-free for at least 7-10 days. The tablet should be swallowed whole with water and taken at approximately the same time each day to maintain consistent plasma levels. Dosage adjustments are not typically required for renal or hepatic impairment, though caution is advised in patients with moderate to severe liver disease. Treatment duration varies based on individual response but often continues for 3-6 months or longer depending on clinical progress.
Precautions
Patients should be monitored for signs of depression or suicidal ideation, particularly during early treatment. Liver function tests should be performed before initiation and periodically during therapy due to potential hepatotoxicity. Use with caution in patients with renal impairment (creatinine clearance <30 mL/min). Avoid abrupt discontinuation without medical consultation. Patients should carry identification stating they are taking naltrexone in case emergency treatment with opioids is required. Not recommended for use during acute alcohol withdrawal.
Contraindications
Naltrexone is contraindicated in patients receiving opioid analgesics, those with current physiologic opioid dependence, or those in acute opioid withdrawal. It must not be used in patients with acute hepatitis or liver failure. Hypersensitivity to naltrexone or any component of the formulation prohibits use. The medication is contraindicated in patients who have failed the naloxone challenge test or have a positive urine screen for opioids.
Possible side effects
Common side effects (≥5% incidence) include nausea (10%), headache (7%), dizziness (4-10%), nervousness (4-7%), fatigue (4-10%), and insomnia (3-10%). Less frequently reported effects include anxiety, vomiting, decreased appetite, joint and muscle pain. Rare but serious adverse reactions may include hepatotoxicity (elevated transaminases), depression, suicidal ideation, eosinophilic pneumonia, and hypersensitivity reactions. Most side effects are mild to moderate and tend to diminish within the first few weeks of treatment.
Drug interaction
Naltrexone may precipitate acute withdrawal in opioid-dependent patients. It antagonizes the effects of opioid analgesics, opioid antitussives, and antidiarrheal medications. Concurrent use with hepatotoxic drugs (including acetaminophen) may increase risk of liver damage. Caution is advised when administering with medications that affect hepatic metabolism. No clinically significant interactions with disulfiram have been observed, though combined use requires careful monitoring.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Doubling doses to make up for a missed dose is not recommended. Patients should contact their healthcare provider if multiple doses are missed to discuss treatment continuation.
Overdose
In case of suspected overdose, seek immediate medical attention. Symptoms may include nausea, vomiting, abdominal pain, dizziness, and lethargy. There is no specific antidote for naltrexone overdose. Treatment is supportive and symptomatic. Hemodialysis is not effective for enhancing elimination. In cases where opioid analgesia is required for pain management, larger than usual doses may be needed under close medical supervision.
Storage
Store at controlled room temperature (20-25°C or 68-77°F) with excursions permitted between 15-30°C (59-86°F). Keep in the original container with the lid tightly closed. Protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication through medication take-back programs.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Naltrexone HCl is available by prescription only and should be used under appropriate medical supervision. Individual results may vary. Always consult with a qualified healthcare professional before starting or changing any medication regimen. Not all possible uses, precautions, side effects, or interactions are listed here.
Reviews
Clinical studies demonstrate that naltrexone significantly improves abstinence rates compared to placebo. In a 12-week randomized controlled trial, 49% of naltrexone-treated patients remained abstinent versus 23% in the placebo group. Patient reports frequently note reduced “mental obsession” with alcohol and decreased pleasure from drinking if relapse occurs. Some users report initial side effects that typically subside within 1-2 weeks. Success rates are highest when combined with comprehensive behavioral therapy and support systems.